Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV005387703 | SCV006036918 | uncertain significance | not specified | 2025-01-08 | criteria provided, single submitter | clinical testing | The c.311C>G (p.S104W) alteration is located in exon 2 (coding exon 2) of the NPC1L1 gene. This alteration results from a C to G substitution at nucleotide position 311, causing the serine (S) at amino acid position 104 to be replaced by a tryptophan (W). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |